What does a positive hepatitis C antibody result by chemiluminescent immunoassay indicate and what are the appropriate next steps in management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

A positive hepatitis C antibody by chemiluminescent immunoassay requires immediate HCV RNA testing to determine if you have current infection versus past resolved infection.

The critical next step is to obtain HCV RNA testing on the same blood sample (or at the same visit) to distinguish between active infection requiring treatment and past cleared infection. 1

What the Positive Antibody Means

A reactive HCV antibody test indicates one of three possibilities:

  • Current active HCV infection (most important to identify)
  • Past HCV infection that has spontaneously resolved
  • Biologic false-positive result (particularly if the signal-to-cutoff ratio is low)

The antibody test alone cannot distinguish between these scenarios, which is why RNA testing is mandatory 1.

Immediate Management Algorithm

Step 1: HCV RNA Testing

  • Must be performed reflexively on the same blood sample when antibody is reactive 2
  • Single-visit sample collection is now the standard of care to avoid incomplete testing 2
  • Historically, one-third of patients had incomplete testing when RNA wasn't automatically ordered, leading to missed diagnoses 2

Step 2: Interpretation Based on RNA Result

If HCV RNA is DETECTED:

  • You have current active HCV infection 1
  • Requires immediate linkage to medical care and treatment 1
  • Before starting antiviral therapy, retest HCV RNA on a subsequent blood sample to confirm positivity 1
  • Proceed with quantitative HCV RNA and genotype testing 3
  • Assess degree of liver fibrosis (biopsy or noninvasive testing) 3

If HCV RNA is NOT DETECTED:

  • No current infection present 1
  • Represents either past resolved infection or false-positive antibody
  • Generally no further action required in most cases 1
  • Exception: If you have suspected recent exposure (within 6 months), clinical evidence of liver disease, or specimen handling concerns, follow-up RNA testing is warranted 1

Important Caveats About False-Positives

The signal-to-cutoff (S/CO) ratio matters significantly:

  • Very low S/CO ratios (e.g., <4.32) have much higher false-positive rates 4
  • In low-risk populations, false-positivity can be substantial 4
  • Research shows critical thresholds: S/CO <5 for some assays carries higher false-positive risk 5
  • If antibody is reactive but RNA is negative, and you want to distinguish true past infection from false-positive, consider testing with a different HCV antibody assay 1

Counseling Requirements

While awaiting RNA results or if infection is confirmed, provide counseling on 6:

  • Avoiding hepatotoxic substances: alcohol, excessive acetaminophen
  • Preventing transmission: safer injection practices if applicable, safer sex practices
  • Referral to addiction medicine if injection drug use is involved 6

Critical Pitfall to Avoid

Never stop at just the antibody test. The single most common error is incomplete testing—ordering antibody without ensuring RNA testing occurs 2. This leaves patients undiagnosed and untreated. Modern practice requires automatic reflex RNA testing on all reactive antibody samples to ensure complete diagnostic workup in a single visit 2.

Related Questions

In a patient with a positive anti‑hepatitis C virus (anti‑HCV) antibody test but an undetectable hepatitis C virus (HCV) RNA polymerase chain reaction (PCR) viral load one month after initiating antiviral therapy, what does this indicate?
What is the recommended treatment for hepatitis C virus infection in adults?
How should a patient with a positive anti‑HCV antibody test be evaluated and managed?
What is the appropriate approach to evaluate and manage a 45-year-old male with incidentally detected reactive hepatitis C virus (HCV) RNA?
In a 46-year-old male with a positive anti‑HCV antibody, HCV RNA of 2,283,553 IU/mL, normal liver function tests, normal abdominal ultrasound, and normal FibroScan, what is the appropriate management?
What is the recommended treatment for uncomplicated genital Chlamydia trachomatis infection?
What is the clinical significance of an M‑spike detected on a 24‑hour urine collection?
How should platelet-rich plasma (PRP) be prepared?
What is the appropriate diagnostic and treatment plan for a 36‑year‑old woman with a 6‑month history of right upper abdominal pain radiating to the back, worsened by acidic drinks, associated nausea and vomiting, and no fever, bowel changes, or prior gastritis/ulcer history?
What is the appropriate fluconazole dosage for moderate to severe oropharyngeal candidiasis?
What is the recommended intramuscular ceftriaxone (Rocephin) dose for treating uncomplicated gonorrhea in an adult, including dosing adjustments for patients weighing ≥150 kg?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.